These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7940703)

  • 1. Evidence that 2-chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation.
    Oberhuber G; Schmid T; Thaler W; Kaltenbacher A; Schirmer M; Liliemark J; Herbst P; Geisen F; Margreiter R; Konwalinka G
    Transplantation; 1994 Sep; 58(6):743-5. PubMed ID: 7940703
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-Chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation.
    Schmid T; Oberhuber G; Thaler W; Kaltenbacher A; Herbst P; Margreiter R; Konwalinka G
    Transplant Proc; 1994 Jun; 26(3):1614. PubMed ID: 7913269
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract]   [Full Text] [Related]  

  • 4. Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation.
    Collins BH; Areford ML; Fabian MA; Jaffee BD; Bollinger RR
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):37-9. PubMed ID: 8516941
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
    Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
    Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
    Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
    Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
    [No Abstract]   [Full Text] [Related]  

  • 7. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
    Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous transplantation of hepatocytes mitigates rejection of small bowel allografts in the rat.
    Sandbichler P; Erhart R; Herbst P; Schmid T; Vogel W; Thaler W; Tötsch M; Klima G; Margreiter R
    Transplant Proc; 1995 Feb; 27(1):631-2. PubMed ID: 7879126
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
    Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
    Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of rapamycin in orthotopic small bowel transplantation in the rat.
    Marquet RL; de Bruin RW; Heineman E; Jeekel J
    Transplant Proc; 1993 Aug; 25(4):2695-6. PubMed ID: 8356718
    [No Abstract]   [Full Text] [Related]  

  • 12. Importance of lymphoid tissue for survival of small bowel allografts.
    Pirenne J; Williams JG; Kim S; Fryer J; Benedetti E; Hakim NS; Médot M; Najarian JS; Gruessner RW; Dunn DL
    Transplant Proc; 1995 Feb; 27(1):1359-60. PubMed ID: 7878911
    [No Abstract]   [Full Text] [Related]  

  • 13. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
    de Bruin RW; HogenEsch H; Heineman E; Jeekel J; Marquet RL
    Transplant Proc; 1991 Dec; 23(6):3257-9. PubMed ID: 1721429
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural killer activity is down-regulated following allogeneic small bowel transplantation.
    Tice DG
    Transplant Proc; 1992 Jun; 24(3):1135-6. PubMed ID: 1604554
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of spleen transplantation and cyclosporine A treatment to ameliorate survival after small bowel transplantation.
    Pirenne J; D'Silva M; Jacquet N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1206. PubMed ID: 8442087
    [No Abstract]   [Full Text] [Related]  

  • 16. Leflunomide and cyclosporine immunomodulation in intestinal xenotransplantation.
    Foster PF; Kociss K; Shen J; Sankary HN; Xiao F; Williams JW
    Transplant Proc; 1996 Oct; 28(5):2527-8. PubMed ID: 8907935
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that graft-versus-host reaction and rejection can occur simultaneously after allogeneic small-bowel transplantation.
    Johnsson C; Gannedahl G; Tufveson G
    Transplant Proc; 1995 Dec; 27(6):3548-9. PubMed ID: 8540096
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppression in small bowel transplantation--treatment with a monoclonal IL-2 receptor antibody (NDS 61).
    Schweizer E; Papachrysanthou A; Faendrich F; Deltz E; Schroeder P
    Transplant Proc; 1994 Dec; 26(6):3142-3. PubMed ID: 7998095
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive effects of leflunomide in a cardiac allograft model.
    Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term survival and tolerance in allogeneic rat small bowel transplant recipients treated with cyclosporine.
    Diflo T; Maki T; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2885-6. PubMed ID: 2650392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.